Sufentanil-Dezocine Combination in Patient-Controlled Intravenous Analgesia for Postoperative Pain After Pancreatic Cancer Surgery: A Retrospective Propensity Score-Matched Study
The combination of sufentanil and dezocine provides superior postoperative analgesia without increasing clinically relevant adverse effects, making it a promising option for pain management in pancreatic surgery patients. Further research is warranted to validate its routine clinical use.
Authors
- Yimeng Xia (ORCID: https://orcid.org/0000-0001-5187-657X)
- Yan Luo (ORCID: https://orcid.org/0000-0003-0431-3162)
- Zhi-Hua Huang (ORCID: https://orcid.org/0000-0002-3428-502X)
- Jian Li (ORCID: https://orcid.org/0000-0003-0901-6458)
- Qiang Li (ORCID: https://orcid.org/0000-0002-4897-1012)
- Xiao‐Xing Song
- Xiaoying Xu (ORCID: https://orcid.org/0000-0001-7613-6260)
Institutions
- Shanghai Jiao Tong University (CN)
- Ruijin Hospital (CN)
Publication Details
- Journal
- Journal of Pain Research
- Published
- 2025-10-01
- DOI
- https://doi.org/10.2147/jpr.s528699
- Primary Topic
- Pain Management and Opioid Use
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China